Rituximab induced myocardial infarction: A fatal drug reaction

被引：23

作者：

Arunprasath, Palamalai ^{[1
]}

Gobu, Pakkirisamy ^{[1
]}

Dubashi, Biswajit ^{[2
]}

Satheesh, Santhosh ^{[1
]}

Balachander, Jayaraman ^{[1
]}

机构：

[1] JIPMER, Dept Cardiol, Pondicherry, India

[2] JIPMER, Dept Med Oncol, Pondicherry, India

来源：

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS | 2011年 / 7卷 / 03期

关键词：

ANTI-CD20; MONOCLONAL-ANTIBODY;

D O I：

10.4103/0973-1482.87003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：346 / U185

页数：3

共 4 条

[1]

Aronson J.K., 2009, Meyler's Side Effects ofAnalgesics and Anti-Inflammatory Drugs, V15th

[2] European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma [J].

Foran, JM ;

Rohatiner, AZS ;

Cunningham, D ;

Popescu, RA ;

Solal-Celigny, P ;

Ghielmini, M ;

Coiffier, B ;

Johnson, PWM ;

Gisselbrecht, C ;

Reyes, F ;

Radford, JA ;

Bessell, EM ;

Souleau, B ;

Benzohra, A ;

Lister, TA .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) :317-324

[3]

*GEN, GEN PROD PROD INF RI

[4] Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an Anti-CD20 monoclonal antibody (Rituximab, IDEC-C2B8) [J].

Winkler, U ;

Jensen, M ;

Manzke, O ;

Schulz, H ;

Diehl, V ;

Engert, A .

BLOOD, 1999, 94 (07) :2217-2224

← 1 →